CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?

R Nijmeijer, W K Lagrand, C A Visser, C J Meijer, H W Niessen, C E Hack

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)403-14
Number of pages12
JournalINTERNATIONAL IMMUNOPHARMACOLOGY
Volume1
Issue number3
Publication statusPublished - Mar 2001

Cite this

@article{dadf6a70c1324ab9b400d0ae8b562201,
title = "CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?",
keywords = "Animals, C-Reactive Protein, Complement Activation, Complement Inactivator Proteins, Complement System Proteins, Humans, Myocardial Infarction, Myocardial Ischemia, Journal Article, Research Support, Non-U.S. Gov't, Review",
author = "R Nijmeijer and Lagrand, {W K} and Visser, {C A} and Meijer, {C J} and Niessen, {H W} and Hack, {C E}",
year = "2001",
month = "3",
language = "English",
volume = "1",
pages = "403--14",
journal = "INTERNATIONAL IMMUNOPHARMACOLOGY",
issn = "1567-5769",
publisher = "Elsevier",
number = "3",

}

CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? / Nijmeijer, R; Lagrand, W K; Visser, C A; Meijer, C J; Niessen, H W; Hack, C E.

In: INTERNATIONAL IMMUNOPHARMACOLOGY, Vol. 1, No. 3, 03.2001, p. 403-14.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?

AU - Nijmeijer, R

AU - Lagrand, W K

AU - Visser, C A

AU - Meijer, C J

AU - Niessen, H W

AU - Hack, C E

PY - 2001/3

Y1 - 2001/3

KW - Animals

KW - C-Reactive Protein

KW - Complement Activation

KW - Complement Inactivator Proteins

KW - Complement System Proteins

KW - Humans

KW - Myocardial Infarction

KW - Myocardial Ischemia

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

M3 - Review article

VL - 1

SP - 403

EP - 414

JO - INTERNATIONAL IMMUNOPHARMACOLOGY

JF - INTERNATIONAL IMMUNOPHARMACOLOGY

SN - 1567-5769

IS - 3

ER -